Skip to Content

93 5514 93 5514 (Carbamazepine Extended-Release 300 mg)

Pill with imprint 93 5514 93 5514 is Green / Black, Capsule-shape and has been identified as Carbamazepine Extended-Release 300 mg. It is supplied by Teva Pharmaceuticals USA Inc..

Carbamazepine is used in the treatment of trigeminal neuralgia; bipolar disorder; schizoaffective disorder; epilepsy and belongs to the drug class dibenzazepine anticonvulsants. There is positive evidence of human fetal risk during pregnancy. Carbamazepine 300 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for 93 5514 93 5514

Carbamazepine Extended-Release

Imprint
93 5514 93 5514
Strength
300 mg
Color
Green / Black
Size
22.00 mm
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Dibenzazepine anticonvulsants
Pregnancy Category
D - Positive evidence of risk
CSA Schedule
Not a controlled drug
Labeler / Supplier
Teva Pharmaceuticals USA Inc.
National Drug Code (NDC)
00093-5514
Inactive Ingredients
carnauba wax, D&C Yellow No. 10, aluminum oxide, FD&C Green No. 3, gelatin, ferrosoferric oxide, lactose monohydrate, polyethylene glycol 1450, polyethylene glycol (PEG) 4500, propylene glycol, shellac, sodium lauryl sulfate, sorbitan monolaurate, titanium dioxide, povidone, sodium hydroxide

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.